242 related articles for article (PubMed ID: 23335506)
1. LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivo.
Tate CM; Blosser W; Wyss L; Evans G; Xue Q; Pan Y; Stancato L
J Biol Chem; 2013 Mar; 288(9):6743-53. PubMed ID: 23335506
[TBL] [Abstract][Full Text] [Related]
2. Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity.
Campbell RM; Anderson BD; Brooks NA; Brooks HB; Chan EM; De Dios A; Gilmour R; Graff JR; Jambrina E; Mader M; McCann D; Na S; Parsons SH; Pratt SE; Shih C; Stancato LF; Starling JJ; Tate C; Velasco JA; Wang Y; Ye XS
Mol Cancer Ther; 2014 Feb; 13(2):364-74. PubMed ID: 24356814
[TBL] [Abstract][Full Text] [Related]
3. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
[TBL] [Abstract][Full Text] [Related]
4. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
Yego EC; Dillman JF
Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
[TBL] [Abstract][Full Text] [Related]
5. Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.
Rose BA; Yokota T; Chintalgattu V; Ren S; Iruela-Arispe L; Khakoo AY; Minamisawa S; Wang Y
J Biol Chem; 2017 Aug; 292(31):12787-12800. PubMed ID: 28637870
[TBL] [Abstract][Full Text] [Related]
6. IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway.
Meng F; Yamagiwa Y; Taffetani S; Han J; Patel T
Am J Physiol Cell Physiol; 2005 Oct; 289(4):C971-81. PubMed ID: 15917303
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid induces brain endothelial cell apoptosis via p38-MAPK and intracellular calcium signaling.
Evans J; Ko Y; Mata W; Saquib M; Eldridge J; Cohen-Gadol A; Leaver HA; Wang S; Rizzo MT
Microvasc Res; 2015 Mar; 98():145-58. PubMed ID: 24802256
[TBL] [Abstract][Full Text] [Related]
8. SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation.
Sreekanth GP; Chuncharunee A; Sirimontaporn A; Panaampon J; Noisakran S; Yenchitsomanus PT; Limjindaporn T
PLoS One; 2016; 11(2):e0149486. PubMed ID: 26901653
[TBL] [Abstract][Full Text] [Related]
9. A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer.
Patnaik A; Haluska P; Tolcher AW; Erlichman C; Papadopoulos KP; Lensing JL; Beeram M; Molina JR; Rasco DW; Arcos RR; Kelly CS; Wijayawardana SR; Zhang X; Stancato LF; Bell R; Shi P; Kulanthaivel P; Pitou C; Mulle LB; Farrington DL; Chan EM; Goetz MP
Clin Cancer Res; 2016 Mar; 22(5):1095-102. PubMed ID: 26581242
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.
Ferrari G; Terushkin V; Wolff MJ; Zhang X; Valacca C; Poggio P; Pintucci G; Mignatti P
Mol Cancer Res; 2012 May; 10(5):605-14. PubMed ID: 22522454
[TBL] [Abstract][Full Text] [Related]
11. High-content screening analysis of the p38 pathway: profiling of structurally related p38alpha kinase inhibitors using cell-based assays.
Ross S; Chen T; Yu V; Tudor Y; Zhang D; Liu L; Tamayo N; Dominguez C; Powers D
Assay Drug Dev Technol; 2006 Aug; 4(4):397-409. PubMed ID: 16945013
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of TNF-induced expression of ICAM-1 and IL-8 in human lung microvascular endothelial cells: an obligatory role for the p38 MAPK-MK2 pathway dissociated with HSP27.
Su X; Ao L; Zou N; Song Y; Yang X; Cai GY; Fullerton DA; Meng X
Biochim Biophys Acta; 2008 Sep; 1783(9):1623-31. PubMed ID: 18486623
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 assembles a proangiogenic signaling module consisting of caveolin-1, tumor necrosis factor receptor-associated factor 6, p38-mitogen-activated protein kinase (MAPK), and MAPK-activated protein kinase 2 in endothelial cells.
Jagielska J; Kapopara PR; Salguero G; Scherr M; Schütt H; Grote K; Schieffer B; Bavendiek U
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1280-8. PubMed ID: 22345171
[TBL] [Abstract][Full Text] [Related]
14. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice.
Kim AL; Labasi JM; Zhu Y; Tang X; McClure K; Gabel CA; Athar M; Bickers DR
J Invest Dermatol; 2005 Jun; 124(6):1318-25. PubMed ID: 15955110
[TBL] [Abstract][Full Text] [Related]
15. Selective requirement of p38alpha MAPK in cytokine-dependent, but not antigen receptor-dependent, Th1 responses.
Berenson LS; Yang J; Sleckman BP; Murphy TL; Murphy KM
J Immunol; 2006 Apr; 176(8):4616-21. PubMed ID: 16585552
[TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
Issbrücker K; Marti HH; Hippenstiel S; Springmann G; Voswinckel R; Gaumann A; Breier G; Drexler HC; Suttorp N; Clauss M
FASEB J; 2003 Feb; 17(2):262-4. PubMed ID: 12490545
[TBL] [Abstract][Full Text] [Related]
17. p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells.
Browne AJ; Göbel A; Thiele S; Hofbauer LC; Rauner M; Rachner TD
Cell Death Dis; 2016 Feb; 7(2):e2119. PubMed ID: 26913608
[TBL] [Abstract][Full Text] [Related]
18. JTT-705 blocks cell proliferation and angiogenesis through p38 kinase/p27(kip1) and Ras/p21(waf1) pathways.
Miura S; Matsuo Y; Kawamura A; Saku K
Atherosclerosis; 2005 Oct; 182(2):267-75. PubMed ID: 16159599
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract][Full Text] [Related]
20. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
Sodhi A; Montaner S; Patel V; Zohar M; Bais C; Mesri EA; Gutkind JS
Cancer Res; 2000 Sep; 60(17):4873-80. PubMed ID: 10987301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
